Publication	Data		Fish	Anatomy
Arnold et al., 2022	Fig. 4		nim5Tg; y7Tg + MO3-vegfc	facial lymphatic network endothelial cell mafba expression decreased amount, abnormal facial lymphatic network endothelial cell mafbb expression decreased amount, abnormal
Cohen et al., 2020	Fig. 2		y1Tg + MO2-vegfc	cranial blood vessel lacks all parts of type primordial hindbrain channel, abnormal primordial hindbrain channel angiogenesis decreased process quality, abnormal
	Fig. 3		y1Tg + MO2-vegfc	trunk has fewer parts of type vascular lymphangioblast, abnormal trunk lymphatic endothelial cell differentiation decreased occurrence, abnormal
	Fig. 4		y1Tg + MO2-vegfc	thoracic duct lymphangiogenesis decreased process quality, abnormal trunk lacks all parts of type thoracic duct, abnormal
Gancz et al., 2019	Figure 2		vegfcum18/+; nz101Tg	bulbus arteriosus lymphangiogenic sprout decreased amount, abnormal
	Figure 3		vegfcum18/+; nz101Tg; y1Tg	bulbus arteriosus lymphangiogenic sprout decreased amount, abnormal bulbus arteriosus lymphangiogenic sprout decreased length, abnormal cardiac ventricle lymph vessel absent, abnormal cardiac ventricle lymph vessel agenesis, abnormal
	Figure 4		vegfcum18/+; nz101Tg; y1Tg	cardiac ventricle lacks parts or has fewer parts of type cardiac lymphatic endothelial cluster, abnormal
Bower et al., 2017	Fig. S7		vegfchu5055/hu5055; nz101Tg; y7Tg ,   vegfchu5055/hu5055; nim5Tg; nz101Tg; uq8bhTg	midbrain lymph vessel has fewer parts of type endothelial cell, abnormal
Bower et al., 2017	Fig. 1		vegfchu5055/hu5055; nz101Tg; y7Tg	facial lymphatic vessel lymphangiogenesis decreased occurrence, abnormal lateral facial lymph vessel endothelial cell decreased amount, abnormal medial facial lymph vessel endothelial cell decreased amount, abnormal otolithic lymph vessel endothelial cell decreased amount, abnormal
	Fig. 2		vegfchu5055/hu5055; y1Tg	lymphangioblast cord lymph vessel development decreased occurrence, abnormal
	Fig. 3		vegfchu5055/hu5055; y1Tg	thoracic duct decreased amount, abnormal thoracic duct lymph vessel development decreased occurrence, abnormal
Kärpanen et al., 2017	Fig. 4		vegfchu6410/hu6410; y1Tg	posterior cardinal vein ab9-mapk labeling decreased distribution, abnormal
Yan et al., 2017	Fig. 5		y1Tg + MO1-vegfc	lymphangiogenesis decreased occurrence, abnormal lymphangiogenic sprout decreased amount, abnormal
	Fig. 6		y1Tg + MO1-vegfc	thoracic duct absent, abnormal thoracic duct lymphangiogenesis decreased occurrence, abnormal vascular lymphangioblast absent, abnormal vascular lymphangioblast lymphangiogenesis decreased occurrence, abnormal
Shin et al., 2016	Fig. 2		vegfcum18/um18; y1Tg ,   vegfcum18/+; y1Tg	primordial hindbrain channel absent, abnormal primordial hindbrain channel malformed, abnormal primordial hindbrain channel vasculature development decreased occurrence, abnormal thoracic duct absent, abnormal thoracic duct lymph vessel development decreased occurrence, abnormal thoracic duct lymph vessel development process quality, abnormal thoracic duct malformed, abnormal
	Fig. 3		vegfcum18/um18; y1Tg ,   vegfcum18/+; y1Tg ,   vegfcum18/um18	intersegmental artery increased amount, abnormal intersegmental vein decreased amount, abnormal lymphangiogenic sprout decreased amount, abnormal
	Fig. 6		vegfcum18/um18	digestive system anatomical region edematous, abnormal eye anatomical region edematous, abnormal heart anatomical region edematous, abnormal swim bladder inflation decreased occurrence, abnormal
	Fig. 7		vegfcum18/um18; y1Tg ,   vegfcum18/um18; nz101Tg	lateral facial lymph vessel closed, abnormal lateral facial lymph vessel lymph vessel development process quality, abnormal lateral facial lymph vessel lymphangiogenic sprout absent, abnormal lateral facial lymph vessel lymphangiogenic sprout DsRed expression absent, abnormal lateral facial lymph vessel malformed, abnormal lateral facial lymph vessel truncated, abnormal otolithic lymph vessel absent, abnormal otolithic lymph vessel DsRed expression absent, abnormal
Schuermann et al., 2015	Fig. 3		vegfchu6410/hu6410; y1Tg	primordial hindbrain channel aplastic, abnormal primordial hindbrain channel blood vessel development decreased occurrence, abnormal
Astin et al., 2014	Fig. 1		nz150Tg + MO4-vegfc ,   nz150Tg + MO3-vegfc ,   vegfchu5055/hu5055; nz150Tg	facial lymphatic vessel lymphangiogenesis decreased process quality, abnormal thoracic duct aplastic, abnormal thoracic duct lymphangiogenesis decreased process quality, abnormal
	Fig. 2		nz150Tg + MO3-vegfc	thoracic duct lymphangiogenesis decreased process quality, abnormal
	Fig. S2		nz150Tg + MO3-vegfc	posterior cardinal vein lacks parts or has fewer parts of type lymphangiogenic sprout, abnormal
	Fig. S3		vegfchu5055/hu5055; nz101Tg	cranial vasculature lymphatic system decreased functionality, abnormal
	Fig. S5		nz101Tg; s843Tg + MO3-vegfc	intestine lymphangiogenesis decreased process quality, abnormal
Kim et al., 2014	Fig. 5		s896Tg; y7Tg + MO1-vegfc	lymph vessel development process quality, abnormal lymph vessel endothelium endothelial cell decreased amount, abnormal
Le Guen et al., 2014	Fig. 1		vegfchu6124/hu6124 ,   vegfchu5055/+ ,   vegfchu5142/hu5142 ,   vegfchu5055/hu5055; y1Tg ,   vegfchu6124/+ ,   vegfchu6410/hu6410 ,   vegfchu5055/+; vegfchu6410/+ ,   vegfchu6410/+ ,   vegfchu5055/hu5055 ,   vegfchu5142/+	lymph vasculature absent, abnormal lymphangioblast cord lymphangioblast decreased amount, abnormal lymphangiogenesis disrupted, abnormal thoracic duct absent, abnormal thoracic duct decreased length, abnormal
	Fig. 2		vegfchu5055/hu5055; s896Tg; y1Tg	thoracic duct absent, abnormal
	Fig. S1		vegfchu6124/hu6124; y1Tg	ball edematous, abnormal lymph vasculature absent, abnormal
Cermenati et al., 2013	Fig. 2		y1Tg + MO2-vegfc	posterior cardinal vein vascular sprouts decreased amount, abnormal vascular lymphangioblast decreased amount, abnormal
Helker et al., 2013	Fig. 7		vegfchu6410/hu6410; y1Tg	common cardinal vein blood vessel endothelial cell decreased amount, abnormal endothelial cell proliferation decreased rate, abnormal
Kwon et al., 2013	Fig. 6		ml2Tg; ncv1Tg + MO4-vegfc	motor neuron axon guidance process quality, abnormal
Villefranc et al., 2013	Fig. 1		vegfcum18/um18; y1Tg/y1Tg ,   vegfcum18/+; y1Tg	lymphangioblast cord absent, abnormal lymphangiogenesis disrupted, abnormal primordial hindbrain channel absent, abnormal
	Fig. S2		vegfcum18/um18; y1Tg/y1Tg ,   vegfcum18/+; y1Tg	lymphangiogenesis disrupted, abnormal thoracic duct absent, abnormal
	Fig. S3		vegfcum18/um18; y1Tg/y1Tg ,   vegfcum18/+; y1Tg	angiogenesis disrupted, abnormal intersegmental artery increased amount, abnormal intersegmental vein decreased amount, abnormal lymphangiogenesis disrupted, abnormal vascular lymphangioblast absent, abnormal vascular lymphangioblast cellular motility, abnormal vascular lymphangioblast decreased amount, abnormal
Gore et al., 2011	Fig. 7		y1Tg/y1Tg + MO1-vegfc	angiogenesis disrupted, abnormal intersegmental vessel absent, abnormal
Flores et al., 2010	Fig. 6		WT + MO3-vegfc + MO4-vegfc	lymph vessel development disrupted, abnormal
Hogan et al., 2009	Fig. 2		y1Tg + MO1-vegfc + MO2-vegfc ,   hu4453Tg + MO1-vegfc + MO2-vegfc ,   WT + MO1-vegfc + MO2-vegfc	lymphangiogenesis disrupted, abnormal trunk lymph vasculature aplastic, abnormal
Hogan et al., 2009	Fig. 3		y1Tg + MO1-vegfc	blood vessel development disrupted, abnormal lymph vessel development disrupted, abnormal primordial hindbrain channel aplastic, abnormal thoracic duct aplastic, abnormal
Yaniv et al., 2007	Fig. 2		y1Tg + MO2-vegfc	lymphangiogenesis disrupted, abnormal thoracic duct aplastic, abnormal